Open Access

Proprietary Rights Notice for Journal of Rheumatic Diseases Online

creative commons licenses

1. The person using Journal of Rheumatic Diseases may use, reproduce, disseminate, or display the open access version of content from this journal for non-commercial purposes.

2. ANY USE of the Open Access version of this Journal in whole or in part must include the customary bibliographic citation, including author and publisher attribution, date, article title, Journal of Rheumatic Diseases, and the URL https://www.jrd.or.kr and MUST include a copy of the copyright notice. If an original work is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.

3. For any commercial use of materials from the Open Access version of the journal, permission MUST be obtained from the Journal of Rheumatic Diseases (or Korean College of Rheumatology). E-mail: webmaster@rheum.or.kr

4. Commercial use is defined as being ANY kind of re-use for the commercial gain of the user, their employing institution and/or any other third party. Examples of commercial use include:

a. re-use by a non-author/third party/other publisher of parts of or all of an article or articles in another publication (journal or book) to be sold for commercial purposes

b. the proactive supply of multiple print or electronic copies of items taken from the Journal to third parties on a systematic basis for marketing purposes

c. re-use by an author of parts of or all of an article in other publications from commercial organizations

JRD
Apr 01, 2024 Vol.31 No.2, pp. 108~96
COVER PICTURE
Schematic diagram for mechanism of botanical drugs and ingredients for health functional food for treatment of OA. OA: osteoarthritis, IL: interleukin, TNF-α: tumor necrosis factor-alpha, PGE2: prostaglandin E2, MMP: matrix metalloproteinase, VAS: visual analogue scale. (J Rheum Dis 2024;31:68-78)

Most Keyword ?

What is Most Keyword?

  • It is most registrated keyword in articles at this journal during for 2 years.

Most Read

Most Cited

Editorial Office

Journal of Rheumatic Diseases

pISSN 2093-940X
eISSN 2233-4718
qr-code Download